SphingomonaspaucimobilisBloodstream Infections Associated with Contaminated Intravenous Fentanyl1
Open Access
- 1 January 2009
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 15 (1), 12-18
- https://doi.org/10.3201/eid1501.081054
Abstract
Compounding pharmacies should be required to follow good manufacturing practices, including end-product sterility testing.Keywords
This publication has 24 references indexed in Scilit:
- Trying Times at the FDA — The Challenge of Ensuring the Safety of Imported PharmaceuticalsNew England Journal of Medicine, 2008
- A Multistate Outbreak of Serratia marcescens Bloodstream Infection Associated with Contaminated Intravenous Magnesium Sulfate from a Compounding PharmacyClinical Infectious Diseases, 2007
- Editorial Commentary:Improving and Enforcing Compounding Pharmacy Practices to Protect PatientsClinical Infectious Diseases, 2006
- Outbreak ofSerratia marcescensInfections following Injection of Betamethasone Compounded at a Community PharmacyClinical Infectious Diseases, 2006
- Impact ofUnited States Pharmacopeiachapter 797: Results of a national surveyAmerican Journal of Health-System Pharmacy, 2006
- Postoperative endophthalmitis caused by Sphingomonas paucimobilisJournal of Cataract & Refractive Surgery, 2006
- Pseudomonas putida Septicemia in a Special Care Nursery Due to Contaminated Flush Solutions Prepared in a Hospital PharmacyJournal of Clinical Microbiology, 2005
- Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patientsJournal of Hospital Infection, 2002
- How to Select and Interpret Molecular Strain Typing Methods for Epidemiological Studies of Bacterial Infections: A Review for Healthcare EpidemiologistsInfection Control & Hospital Epidemiology, 1997
- Tracheal colonization with Sphingomonas paucimobilis in mechanically ventilated neonates due to contaminated ventilator temperature probesJournal of Hospital Infection, 1996